Recently, the FDA added a new warning to fluoroquinolone antibiotics based on review of adverse event reporting and four observational studies. This updated labeling highlights the risk of aortic aneurysm rupture or dissection, and is in addition to multiple other warnings that already exist with this drug class. These risks can occur with oral and…
Despite the reliance on medications to treat chronic disease in the U.S., there is ample evidence that patients continue to struggle with achieving intended outcomes, adverse events, polypharmacy, adherence and access. AHP recognizes the importance of pursuing solutions to suboptimal medication use in healthcare and is committed to implementing systematic approaches to optimize value-based medication…
Our FIT kit initiative is now fully underway! As our Colorectal Cancer Screening Guidelines indicate, a colonoscopy should be the first line of screening, however the second line should be a Fecal Immunochemical Test (FIT) kit if a colonoscopy is not possible. While we are performing well across all our contracts on CRC screening, there…
Webinar: Ask the LARC Expert Wednesday, 2/27 @ 12:15pm Featuring Guest Speaker: Katherine Greenberg, MD Vice Chair, Diversity and Culture Development, Department of Pediatrics Director, Gender Health Services, Division of Adolescent Medicine, Department of Pediatrics Division of General Gynecology, Department of Obstetrics and Gynecology As a follow-up to AHP’s LARC Training in December, we’d like…
At the end of 2018 we took a comparative look at how we were performing on our contracted measures in relation to the close of 2017. Of note, we have a slight downward trend across the network within our pediatric preventive measures. Childhood immunizations are down by 1.75% from last year at this time, and…
Rochester Lifestyle Medicine Institute, one of the recipients of AHP’s Population Health Award Grants, is looking for physicians to participate in an educational pilot aimed at reducing chronic disease through plant-based nutrition. Physicians will attend a 12-hour CME/MOC plant-based nutrition course and then recruit 5 of their own patients to complete a whole-food plant-based diet…
As the New Year begins the AHP Optimization Team has started to shift gears in its focus on measures and projects. The team will continue to focus on colorectal cancer screening and fall risk, and add breast cancer screening, well child 3-6 years, and hypertension blood pressure control to its list of measures to optimize….
Laura Jean Shipley, MD, AHP’s Pediatric Medical Director, has assumed a more full-time role here at Accountable Health Partners. Dr. Shipley will now spend 70% of her time devoted to AHP’s pediatric population health efforts. This change will bolster our network’s ability to bring new initiatives to our growing number of pediatric practices. Dr. Shipley…
This edition of Pharmacy Pearls reviews the new drug baloxavir (Xofluza) and its role in therapy compared to other oral antiviral agents for the treatment of influenza based on currently published data and CDC treatment recommendations.
AHP PCPs participating in the network’s gain-sharing contracts can expect their third-quarter clinical integration payments to arrive in the mail in third week of December. Both AHP’s Excellus and MVP contracts provide for upfront payments to PCPs that support their efforts in meeting the quality goals that trigger gain sharing when we meet financial targets….
